Sign in

CIK 0000748592 · Non-accelerated filer<br>Smaller reporting company

Ernexa Therapeutics Inc.

Sign in to watch
Ticker
ERNA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
311103425
Phone
(617) 798-6700
Business address
1035 CAMBRIDGE STREET, SUITE 18A, CAMBRIDGE, MA, 02141
Former names
Eterna Therapeutics Inc., Brooklyn ImmunoTherapeutics, Inc., NTN BUZZTIME INC, NTN COMMUNICATIONS INC

Securities

  • ERNA Common Stock Nasdaq
  • ERNAW Warrants Nasdaq
  1. 8-K/A Event Exhibits
  2. 8-K Event Material agreement · Unregistered share sale
  3. SC 13G Stake Amended Statement of Ownership
  4. 8-K Event Auditor change
  5. 4 Derivatives Options or other derivatives
  6. 3 Insider Initial Statement of Ownership
  7. 3 Insider Initial Statement of Ownership
  8. 3 Insider Initial Statement of Ownership
  9. 3 Insider Initial Statement of Ownership
  10. 8-K Event Executive or director change
  11. 8-K Event Material agreement
  12. 8-K Event Material agreement · Executive or director change · Regulation FD disclosure
  13. 3 Insider Initial Statement of Ownership
  14. 3 Insider Initial Statement of Ownership
  15. 3 Insider Initial Statement of Ownership
  16. 3 Insider Initial Statement of Ownership
  17. 8-K Event Acquisition or sale completed · Shareholder rights changed · Change in control · Executive or director change · Bylaws or fiscal year change · Other events
  18. 4 Shares withheld for taxes Former Director and CEO gave up 9,944 shares (to pay taxes)
  19. 4 Shares withheld for taxes Former SVP of Finance gave up 6,094 shares (to pay taxes)
  20. 8-K Event Other events

Page 20 of 77 · 1,525 filings